Acquista crypto Mercati Spot FuturesGOLD Earn Centro eventi

Altro

Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange. Windtree Therapeutics, a biotech company that established a BNB treasury strategy last month, fell 77% on Wednesday after the Nasdaq informed the firm it would be delisted from the stock exchange for failing to meet compliance requirements.The noncompliance concerned Nasdaq Listing Rule 5550(a)(2) that requires a company’s stock to maintain a minimum bid price of $1.00 per share, Windtree stated in a filing to the US securities regulator on Tuesday. Nasdaq will suspend WINT trading on Thursday. Windtree (WINT) shares dropped a staggering 77.2% to $0.11 on the news, and are down another 4.7% in after-hours, Google Finance data shows. WINT shares saw a minor rise on July 16, when it announced its BNB treasury strategy, but have fallen over 90% since its July 18 peak.Read more Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange. Windtree Therapeutics, a biotech company that established a BNB treasury strategy last month, fell 77% on Wednesday after the Nasdaq informed the firm it would be delisted from the stock exchange for failing to meet compliance requirements.The noncompliance concerned Nasdaq Listing Rule 5550(a)(2) that requires a company’s stock to maintain a minimum bid price of $1.00 per share, Windtree stated in a filing to the US securities regulator on Tuesday. Nasdaq will suspend WINT trading on Thursday. Windtree (WINT) shares dropped a staggering 77.2% to $0.11 on the news, and are down another 4.7% in after-hours, Google Finance data shows. WINT shares saw a minor rise on July 16, when it announced its BNB treasury strategy, but have fallen over 90% since its July 18 peak.Read more

BNB treasury firm plunges 77% after Nasdaq delisting notice

Autore: Coinstats

Fonte: Coinstats

2025/08/21 12:22

1 min di lettura

BID$0.00808+16.81%

BNB$598.4-1.27%

MORE$0.00004007+0.50%

Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.

Windtree Therapeutics, a biotech company that established a BNB treasury strategy last month, fell 77% on Wednesday after the Nasdaq informed the firm it would be delisted from the stock exchange for failing to meet compliance requirements.

The noncompliance concerned Nasdaq Listing Rule 5550(a)(2) that requires a company’s stock to maintain a minimum bid price of $1.00 per share, Windtree stated in a filing to the US securities regulator on Tuesday. Nasdaq will suspend WINT trading on Thursday.

Windtree (WINT) shares dropped a staggering 77.2% to $0.11 on the news, and are down another 4.7% in after-hours, Google Finance data shows. WINT shares saw a minor rise on July 16, when it announced its BNB treasury strategy, but have fallen over 90% since its July 18 peak.

Opportunità di mercato

Valore CreatorBid (BID)

$0.00808

$0.00808$0.00808

+12.39%

USD

Grafico dei prezzi in tempo reale di CreatorBid (BID)

Get 20 USDT in Just 1 Minute

Deposit $100 to unlock $300 in GOLD positions

Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.